HIV/AIDS Strategy: A Comprehensive Guide
Explore our comprehensive guide on HIV, a critical global health issue. Understand its causes, symptoms, prevention strategies, and the latest research developments. Join us in spreading awareness and combating stigma associated with HIV.
1) Introduction to HIV
Readers, please accept my greetings. Today,
we'll look at HIV and AIDS, including its origins, present situation, and
fundamental knowledge. This knowledge is critical for everyone since it not
only assists people who are afflicted with the condition but also teaches
others on how to avoid its spread.
a) The
Emergence and State of the HIV and AIDS Epidemic
HIV, or Human Immunodeficiency Virus, is a
virus that targets the immune system of the body. It can progress to AIDS
(Acquired Immunodeficiency Syndrome) if left untreated. HIV infection in humans
is thought to have started in Central Africa from a species of chimp, with
research indicating that the virus may have leapt from chimps to people as
early as the late 1800s. The virus traveled slowly across Africa and then into
other areas of the world, and it has been present in the United States since at
least the mid to late 1970s. In the spring of 1981, the first cases of AIDS
were reported in the United States, and by 1983, the virus that causes AIDS,
HIV, had been discovered. Early in the HIV/AIDS epidemic in the United States,
the significance of substance misuse in the spread of AIDS was firmly
established, with injectable drug use identified as a direct route of HIV
infection and transmission. HIV/AIDS is still a major worldwide health concern
today. Despite breakthroughs in medical care and therapy, there is no viable
cure for HIV at the moment. People who develop HIV are infected for life. HIV,
on the other hand, can be managed with adequate medical treatment, and people
living with HIV can live long, healthy lives while protecting their partners.
b) Understanding HIV and AIDS: The Basics
HIV is a retrovirus that infects human immune
system cells, primarily CD4-positive T-cells and macrophages, which are essential
components of the cellular immune system. This infection causes a steady
depletion of the immune system, eventually leading to immunodeficiency. People
with immunodeficiency are far more susceptible to a wide range of diseases and
malignancies, the majority of which are uncommon in the general population.
Because they take advantage of a compromised immune system, diseases linked
with severe immunodeficiency are known as opportunistic infections.
In contrast, AIDS refers to the most severe
phases of HIV infection. If not treated, the majority of HIV-infected persons
acquire AIDS symptoms within eight to ten years. The word AIDS refers to a
group of symptoms and diseases caused by an acquired immune system weakness.
HIV infection has been identified as the root cause of AIDS.
HIV is spread through penetrative (anal or
vaginal) intercourse, blood transfusion, the sharing of infected needles in
healthcare settings and medication injection, as well as between mother and
infant during pregnancy, delivery, and nursing. It is crucial to highlight that
HIV is not easily spread, therefore the chance of infection from a single act
of vaginal intercourse is low. However, transmission through anal intercourse
has been reported to be ten times greater than transmission through vaginal
sex.
In terms of therapy, antiretroviral medications
slow down virus replication and hence its spread inside the body by interfering
with its reproduction process in various ways. These medications can slow the
course of AIDS by lowering the viral load in an infected person.
Finally, knowing HIV and AIDS is critical for
prevention, treatment, and care for people who are infected. It is critical to
be tested and know your HIV status in order to make healthy decisions to avoid
contracting or transmitting HIV. People living with HIV can have long and
healthy lives if they receive good medical treatment.
c) Key Statistics on
HIV
As of 2022, there were around 39 million
HIV-positive persons worldwide. There were 37.5 million adults and 1.5 million
children under the age of 15. Women and girls made up 53% of those surveyed. In
2022, an estimated 1.3 million people worldwide would have contracted HIV,
representing a 38% decrease in new HIV infections since 2010 and a 59% decrease
since the peak in 1995. In 2022, around 86% of persons living with HIV
worldwide knew their HIV status. The remaining 14% (about 5.5 million people)
were unaware they were infected with HIV. By the end of 2022, 29.8 million HIV
patients (76% of all HIV patients) had access to antiretroviral medication
(ART) globally. In 2022, 82% of HIV-positive pregnant women worldwide had
access to ART to prevent HIV transmission to their infants during pregnancy and
delivery. Since the peak in 2004, AIDS-related fatalities have been decreased
by 69%. Around 630,000 individuals died from AIDS-related diseases globally in
2022. There will be 20.8 million HIV-positive persons in eastern and southern
Africa by 2022, 4.8 million in western and central Africa, 6.5 million in Asia
and the Pacific, and 2.3 million in Western and Central Europe and North
America.
In the United States, 32,100 new HIV infections
are expected in 2021. HIV affects around 1.2 million persons in the United
States. Approximately 13% of them are unaware and require testing. year the
United States year 2019, an estimated 34,800 new HIV infections occurred. In
2020, 30,635 persons were diagnosed with HIV in the United States and six
dependent regions, a 17% drop from the previous year, owing to the influence of
the COVID-19 pandemic on HIV prevention, testing, and care-related services.MSM
(men who have sex with men) were responsible for 71% of new HIV infections in
the United States in 2020.
The risk of contracting HIV varies greatly
according to the type of exposure or activity. The risk per 10,000 exposures
for blood transfusion, for example, is 9,250, 63 for needle-sharing during
injectable drug use, 138 for receptive anal intercourse, and 8 for receptive
penile-vaginal intercourse.
iv) Treatment
Success Rates for HIV
Following the extensive adoption of ART, high
rates of treatment success were obtained with systematic management of
multidrug-resistant tuberculosis (MDR-TB) and HIV in Botswana. Treatment
success rates among HIV-uninfected individuals were 79.4% and 73.0%,
respectively.
These figures emphasize the global and national
burden of HIV, progress in lowering new infections and deaths, and continued
problems in ensuring that all individuals living with HIV are aware of their
status and have access to treatment. They also emphasize the significance of
preventative initiatives, especially among high-risk groups.
2) Epidemiology
and Biology of HIV Infection
a) Current Extent of HIV Infection in the
U.S. Population
Approximately 1.2 million persons in the United
States have HIV as of 2021. Approximately 13% are unaware of their illness and
require tests. An estimated 34,800 new HIV infections occurred in the United
States in 2019, with new infections dropping by 8% from 2015 to 2019. In 2020,
30,635 persons were diagnosed with HIV in the United States and its six
dependent countries, a 17% drop from the previous year. This decline is most likely
owing to the COVID-19 pandemic's impact on HIV prevention, testing, and
care-related services. HIV continues to afflict specific populations
disproportionately, including racial and ethnic minorities, as well as
homosexual, bisexual, and other men who have sex with men (MSM). MSM accounted
for 71% of new HIV diagnoses in the United States in 2020. Black/African
American MSM accounted for 26% of new HIV diagnoses and 39% of all MSM
diagnoses, whereas Hispanic/Latino MSM accounted for 21% of new HIV diagnoses
and 31% of all MSM diagnoses.
b) Patterns of Sexual Behavior and Drug Use that Spread HIV
Infection
HIV and other sexually transmitted illnesses
are directly linked to substance use problems. Injection drug use (IDU) can
directly spread HIV if persons exchange infected needles, syringes, or other
injection supplies. Drinking and using, smoking, or inhaling drugs are also
linked to an increased risk of HIV, since these substances affect judgment and
can lead to risky sexual practices (e.g., having sex without a condom, having
numerous partners) that make persons more likely to get and spread HIV.
Some commonly used substances and
their associated HIV risks include
i) Alcohol: Excessive alcohol intake,
particularly binge drinking, has been associated to hazardous sexual behaviors
and can have a poor impact on HIV treatment results.
ii) Opioids: These medicines have been connected
to current HIV epidemics and are associated with HIV risk behaviors such as
needle sharing and unsafe sex.
iii) Methamphetamine: "Meth" is associated
with risky sexual conduct that raises HIV risk and can be injected, which
increases HIV risk if needles and other injection equipment are shared.
iv) Crack cocaine: This stimulant can create a cycle
in which people quickly deplete their resources and turn to various methods of
obtaining the substance, such as exchanging sex for drugs or money, which
increases HIV risk.
iv) Inhalants: Amyl nitrite ("poppers")
usage has historically been associated with hazardous sexual practices, illegal
substance use, and sexually transmitted illnesses in homosexual and bisexual
males.
c) Diagnoses of HIV Infection in the United States and Dependent
Areas
In 2020, 30,635 persons aged 13 and up were
diagnosed with HIV in the United States and its six dependent territories
(American Samoa, Guam, the Northern Mariana Islands, Puerto Rico, the Republic
of Palau, and the United States Virgin Islands). HIV diagnoses are not
uniformly spread between states and regions, with the South having the greatest
incidence of new diagnosis. HIV cases declined by 8% overall in the United
States and dependent countries between 2016 and 2019, however trends varied by
location. Because of the influence of the COVID-19 pandemic on access to HIV
testing, care-related services, and case monitoring operations in state and
local governments, the 2020 statistics should be read with caution.
3) Prevention,
Diagnosis, and Treatment of HIV Infection
a) Prevention Strategies and Principles for HIV
HIV infection prevention techniques are varied
and diverse. They include abstinence (not having sex), never sharing needles,
and properly using condoms every time one has sex. There are other HIV
preventive medications available, such as pre-exposure prophylaxis (PrEP) and
post-exposure prophylaxis (PEP). When applied appropriately and regularly,
these tactics are most successful.
b) Methods for
Evaluating the Effectiveness of Interventions for HIV
Evaluating the success of HIV prevention
programs is a difficult endeavor that necessitates a long-term investment of
time and resources. For each of the major AIDS intervention programs, the Panel
on the Evaluation of AIDS Interventions advises utilizing randomized studies
with alternative-treatment controls. Instead of utilizing a no-treatment
control group, this strategy assesses alternative or improved therapies, making
it more appealing to participants.
Nonexperimental before-and-after evaluation
approaches can be beneficial for analyzing a project's ability to provide
services to its participants, but they are inadequate for determining program
effectiveness. Because alternative explanations for across-time changes in attitudes
and behaviors cannot be ruled out, inferring cause and effect from such designs
is extremely difficult.
c) How do Medicines Slow Down or Stop HIV?
Antiretroviral medications, which prevent the
virus from reproducing in the body, are used to treat HIV. This enables the
immune system to restore itself and avoid additional harm. Because HIV may
swiftly adapt and grow resistant, a combination of HIV medications is utilized.
Some HIV medicines, known as fixed dosage combinations, have been integrated
into a single tablet.
d) Which HIV Medicines are Best to Take?
Each patient's choice of HIV medications is
unique. Different HIV treatment combinations function differently for different
people, therefore the medicine you take will be unique to you. The amount of
HIV virus in your blood (viral load) is evaluated to determine how effective
therapy is. When something can no longer be measured, it is said to be
undetectable. Within 6 months of commencing therapy, the majority of persons
receiving daily HIV medication have an undetectable viral load.
It is crucial to know that many of the HIV
medications might mix with other medications recommended by your doctor or
purchased over the counter. Some of them include nasal sprays and inhalers,
herbal medicines such as St John's wort, and recreational narcotics. Before
taking any other medications, always consult with your HIV clinic staff or your
primary care physician.
4) Impact of
HIV and AIDS
a) Illness,
Death and the Demographic Impact of HIV and AIDS
The impact of HIV and AIDS on population size
and composition is enormous. Deaths from AIDS increase directly in particular
age groups and may also increase indirectly, since orphans, for example, suffer
increased mortality risks. Fertility can be impacted by changes in sexual
behavior as well as biological factors. Communities may be weakened, and
migration may change the population's geographic distribution. AIDS has a
significant demographic impact in Sub-Saharan African countries. For example,
by 2000-05, Sub-Saharan Africa's life expectancy had already fallen 8.8 years
short of what it would have been without AIDS. When compared to a setting
without an AIDS pandemic, the risk of mortality between the ages of 15 and 60 can
be significant. If HIV prevalence is 30%, the risk increases by 65 percentage
points for males and 75 percentage points for females.
b) Economic Growth Rates in Africa: The Potential Impact of
HIV/AIDS
The macroeconomic consequences of HIV/AIDS in
Africa are significant. The epidemic has already decreased average annual
national economic growth rates in Africa by 2-4%. Through increasing mortality
and morbidity, the HIV/AIDS pandemic has an influence on labor supply. This is
exacerbated by the erosion of expertise in critical labor-market areas. In
South Africa, for example, 60% of the mining workforce is between the ages of
30 and 44; in 15 years, this is expected to shrink to 10%. 20% of student
nurses in South Africa's healthcare industry are HIV positive. The prolonged
sickness linked with AIDS affects worker productivity, lowering competitiveness
and earnings.
c) Rising Tide of AIDS Orphans in Southern Africa
South African children have suffered greatly as
a result of the HIV/AIDS epidemic. South Africa is said to have the most AIDS
orphans of any African country. HIV/AIDS-related infections claimed the lives
of nearly half of all orphans in South Africa. Orphans suffer several
challenges as a result of the epidemic, in addition to the trauma of losing
their parents. Orphans often have insufficient food security, which can lead to
malnutrition. When a youngster is orphaned, their access to school is also
likely to be hampered. According to University of Cape Town study, "it is
predicted that South African school enrollment levels will fall dramatically in
the areas worst affected by the epidemic." As a result, orphans tend to
grow up destitute and illiterate, making them prone to HIV infection."
5) Socioeconomic
and Political Aspects for HIV
HIV, the virus that causes AIDS, is firmly
ingrained in social and economic inequalities, disproportionately harming
individuals of lower socioeconomic level and disadvantaged communities. A
person's socioeconomic status might influence their chances of catching HIV and
developing AIDS. Limited economic possibilities and periods of homelessness
have been linked to risky sexual behaviors such as sex for money, drugs,
shelter, food, and safety, which can put people at risk for HIV.
Poverty can also lead to food insecurity, which
can contribute to HIV/AIDS infection. Food insecurity can lead to transactional
sex and power imbalances in sexual interactions, putting an individual at risk
of infection. Furthermore, disadvantaged urban areas have HIV prevalence rates
comparable to many low-income nations with widespread epidemics.
HIV status frequently has a negative influence
on socioeconomic status by limiting a person's capacity to work and generate
revenue. According to research, unemployment rates among those living with
HIV/AIDS might vary from 45 to 65 percent.
b) Development, Numbers, and Politics
In 2022, there will be around 39 million
HIV-positive persons worldwide. In 2022, an estimated 1.3 million people
worldwide would have contracted HIV, representing a 38% decrease in new HIV
infections since 2010 and a 59% decrease since the peak in 1995. Political
action on AIDS has provided a chance to address underlying inequities and
generate good political momentum on subjects like homosexual rights. Politics,
on the other hand, has been a negative factor at times, obstructing critical
policy breakthroughs and evidence-based action on AIDS, including access to
antiretroviral therapy in developing countries, prevention of HIV transmission
via sexual contact, and harm reduction among injectable drug users.
c) Socioeconomic Obstacles to HIV Prevention and Treatment in
Developing Countries
Access to HIV therapy is frequently determined
by socioeconomic class. Poverty, a lack of economic prospects, restricted
healthcare access, and a lack of transportation infrastructure have all been
identified as independent and interactive variables to HIV-positive persons'
health care involvement.
Despite improvements in scientific
understanding of HIV and its prevention and treatment, far too many people
living with or at risk of HIV still lack access to prevention, care, and
treatment, and there is no cure. The HIV epidemic affects not just people'
health, but also households, communities, and nations' development and economic
progress. Many of the nations most affected by HIV also have other infectious
illnesses, food shortages, and other major issues. Finally, the economical and
political dimensions of HIV are intricately interwoven. Addressing these issues
necessitates a multifaceted strategy that involves not just medical
interventions but also social, economic, and political tactics.
6) Treatment
and Prevention Dilemmas for HIV
a) Prevention and Public Health Programs for HIV
The most cost-effective strategy to tackle HIV
is through prevention and public health programs. HIV infection can be avoided
through biological measures such as screening donors and testing donations to
ensure safe blood and blood products. Social treatments that encourage behavior
change, such as the use of condoms, having fewer partners, and practicing
monogamy or abstinence, are also important. Behavior change requires community
mobilization and leadership. While HIV-infected persons can live normal,
productive lives, it is difficult and expensive.
TasP (treatment as prevention) is an effective
HIV prevention and control technique. It is based on the understanding that
early treatment improves clinical results and decreases HIV transmission.
However, implementation issues remain a major barrier in the global effort to
use TasP to reduce HIV transmission and death.
b) Funding Challenges and Ethical Considerations
In the battle against HIV, funding is a major
issue. The CDC's single most significant investment in HIV prevention is
financing for health departments. The fiscal year (FY) 2012 funding cycle
indicated a new path in reaching a better degree of effect with every federal
HIV prevention dollar. The money was focused to four high-impact core areas:
HIV testing, comprehensive HIV prevention with people living with HIV,
including antiretroviral medication, condom distribution, and policy
initiatives. However, ethical issues in HIV prevention research are becoming
increasingly difficult. Prevention approaches should be researched in
populations where they may have the greatest impact. This includes critical
groups as well as teenage girls and young women in high-risk HIV environments.
Ethical concerns for HIV prevention research defend and explain universal
ethical norms for human research in ways that are relevant to participants and
populations, as well as responsive to advances in HIV prevention research.
c) Treatment as Prevention and HIV Therapy Challenges
Several large-scale community-based randomized
studies have focused on the notion of treatment as prevention (TasP) to
investigate the impact of large-scale TasP deployment on HIV transmission.
These studies focused on community-level interventions to promote HIV diagnosis
and ART start in order to improve health and prevent HIV transmission. However,
the trials have shown several potential and problems in meeting the 90-90-90
targets and employing TasP to reduce HIV prevalence in Sub-Saharan Africa.
Finally, the battle against HIV entails a
complicated interaction of preventive and treatment tactics, finance issues,
and ethical concerns. A complete strategy is required, including good public
health initiatives, enough financing, ethical research techniques, and
effective treatment strategies.
7) Real Life
Testimonials and Stories of HIV Survivors
Living with HIV is a unique journey for each person,
and the experiences of long-term survivors can give vital insights into the
condition's struggles and successes. Here are some real-life HIV survivor
experiences and testimonials:
a) Anonymous Survivor: This person was diagnosed with HIV in her early twenties in 1990 and
has lived with the disease into her early fifties. Over the years, she has
witnessed tremendous medical and scientific discoveries, including the finding
that virally suppressed persons cannot sexually transfer the virus. This
survivor has also been involved in the design, development, evaluation, and
delivery of HIV services. She underlines the necessity of focusing not only on
viral suppression, but also on quality of life and physical and mental health.
b) Robert Toth: Diagnosed with HIV decades ago, Robert survived through the 1980s and
1990s AIDS crisis. He has gone through the anguish of being informed he only
has two years to live, as well as the anxiety of not being able to care for
himself. Despite the difficulties, he has lived far longer than projected and
highlights the significance of recognizing the advances achieved in HIV
therapy.
c) Xolani:
Diagnosed with TB and meningitis at the age of 25, Xolani first refused
treatment and became ill with tuberculosis and meningitis. He recovered after
beginning HIV and tuberculosis treatment and now devotes his life to assisting
those newly diagnosed with HIV through the CommLink program in Eswatini. This
initiative matches HIV-positive people on treatment with newly diagnosed people
to help them acquire and stay on life-saving anti-retroviral medication.
d) Maria Mejia: Diagnosed with HIV at the age of 18 in 1991, Maria kept her HIV
diagnosis hidden for over 20 years. She became an HIV activist and campaigner,
organizing two worldwide Facebook support groups and working as a Global
Ambassador for The Well Project. Maria underlines the need of humanizing the
disease and educating the population about HIV.
e) Jonathan Blake: Jonathan
was one of the first people in the UK to be diagnosed with HIV in 1982. He
declined to take AZT, which he feels saved his life. Despite the difficulties,
he has lived his life to the fullest, going without medicine until 1996. He is
currently on a medicine combination that works for him.
f) Hydeia Broadbent: Hydeia was adopted as a baby after being diagnosed with HIV, and her
adoptive parents were told she would not live past the age of five. Despite
this, she has become a famous HIV campaigner, addressing at significant events
such as the Republican National Convention in 1996. She highlights the need of
HIV prevention via education and awareness.
g) Regan Hofmann: Diagnosed with HIV at the age of 28, Regan originally concealed her HIV
status out of fear of stigma. She finally chose to go public and became an
advocate for HIV-positive persons. She has worked with UNAIDS and was the
editor-in-chief of POZ, a journal for individuals living with and impacted by
HIV/AIDS.
h) Magic Johnson: The former NBA star declared in 1991 that he was HIV positive,
surprising the sports world. He is now an entrepreneur and philanthropist, as
well as an advocate for HIV/AIDS prevention and safe sex. He attributes his
long-term survival to his strict treatment regimen, upbeat attitude, and solid
support network.
i) Gideon Mendel: After losing close friends to AIDS in the 1980s, Gideon, a
photographer, decided to utilize his talents to capture the lives of
HIV-positive people all over the world. His art, which spans more than 30
years, is a poignant witness to the epidemic's human toll and the perseverance
of people afflicted by it.
j) Rae Lewis-Thornton: Rae was diagnosed with HIV at the age of 23 and AIDS at the age of 30.
She has been living with the virus for over 30 years. She was the first
African-American woman to have her HIV story featured on the cover of a major
magazine (Essence, 1994). She is now an Emmy Award-winning AIDS activist who
uses her platform to educate others about the infection.
k) Hydeia Broadbent: Born with HIV, Hydeia was adopted as an infant and her adoptive parents
were told she would not live past the age of five. However, she defied the odds
and has become a prominent HIV activist, speaking at notable events such as the
1996 Republican National Convention. She emphasizes the importance of education
and awareness in preventing the spread of HIV.
l) Regan Hofmann: Diagnosed with HIV at the age of 28, Regan
initially kept her status a secret due to fear of stigma. However, she
eventually decided to go public and became an advocate for people living with
HIV. She served as the editor-in-chief of POZ, a magazine for people living
with and affected by HIV/AIDS, and has worked with UNAIDS.
m) Magic Johnson: The former professional basketball player announced he was HIV positive
in 1991, shocking the sports world. He has since become an advocate for
HIV/AIDS prevention and safe sex, as well as an entrepreneur and philanthropist.
He credits his long-term survival to his rigorous treatment regimen, positive
attitude, and strong support system.
n) Gideon Mendel: After losing close friends to AIDS in the
1980s, Gideon, a photographer, decided to use his skills to document the lives
of people living with HIV around the world. His work, which spans more than 30
years, provides a powerful testament to the human toll of the epidemic and the
resilience of those affected by it.
o) Rae Lewis-Thornton: Diagnosed with HIV at the age of 23
and later with AIDS at 30, Rae has lived with the virus for over 30 years. She
became the first African-American woman to share her story of living with HIV
on the cover of a major magazine (Essence, 1994). She has since become an Emmy
Award-winning AIDS activist, using her platform to educate others about the
virus.
These tales illustrate the tenacity and bravery
of those living with HIV. They also emphasize the significance of activism,
education, and awareness in managing and preventing the disease's spread.
8) Initiatives taken
for HIV Awareness
HIV awareness initiatives range from consumer
and public advertising to national and international initiatives,
community-based programs and events, and government and public health
activities.
a) Consumer and Public Campaigns
Several federal agencies have launched public
education and awareness initiatives on HIV prevention, treatment, and care.
Among these campaigns are:
i) "I am a Work
of ART": This
campaign urges persons living with HIV who are not receiving care to seek care,
remain in care, and achieve viral suppression by receiving antiretroviral
medication (ART).
ii) "Let's Stop
HIV Together":
This campaign aims to reduce HIV stigma while also encouraging HIV testing,
prevention, and treatment. It emphasizes the role that everyone can play in
ending HIV stigma and allows those living with HIV, as well as their friends,
family, and supporters, a voice.
iii) "Learn the
Link": The
National Institute on Drug Abuse's (NIDA) "Learn the Link" program
educates teenagers, as well as parents and educators, on how drug and alcohol
use puts them at risk for HIV infection.
b) National and International Initiatives
The National HIV/AIDS Strategy for the United
States (2022-2025) provides a path for stakeholders across the country to
accelerate efforts to end the country's HIV pandemic by 2030. The Strategy has
ambitious goals for eliminating the HIV pandemic in the United States by 2030,
including a 75% decrease in new HIV infections by 2025 and a 90% decrease by
2030.
The President's Emergency Plan for AIDS Relief
(PEPFAR) is the world's greatest commitment to a single illness in history.
These organizations fund a variety of worldwide HIV/AIDS operations, ranging
from research to technical assistance and financial aid to other countries in
order to help prevent new HIV infections and enable individuals living with HIV
to get life-saving treatment.
c) Community-Based Programs and Events
In 2022, the Centers for Disease Control and
Prevention (CDC) began hosting a series of community engagement meetings with
community leaders and people to explore community-driven ideas to promote HIV
prevention, diagnosis, treatment, and outbreak response. These engagement
activities will continue till 2023.
d) Government and Public Health Initiatives
The Office of the Associate Director of
Communication at the Centers for Disease Control and Prevention (CDC) has
produced standards and best practices for executing health communication
campaigns, activities, and emergency response initiatives.
The CDC's Prevention Communication Branch
contributes to DHP objectives by producing, distributing, and evaluating
evidence-based HIV communications and communication initiatives to public
health partners, health care professionals, persons at risk of or living with
HIV, and the general public.
These are just a handful of the many programs
underway to increase awareness about HIV and AIDS, promote prevention, and give
support and treatment to individuals impacted by the illness.
9) Conclusion
To summarize, the HIV epidemic has been a major
worldwide health concern for more than four decades. It has taught us critical
lessons about the rise of new infectious illnesses, the vulnerability of our
blood supply, and the value of preparation and reaction. We have made great
progress in understanding HIV, how it affects the immune system, and how it
advances to AIDS throughout the years. With the development of antiretroviral
treatment (ART), HIV has been changed from a deadly illness to a chronic
condition, allowing persons infected to live long and healthy lives.
It is important to emphasize, however, that
early diagnosis and treatment not only assist the person living with HIV, but
also help prevent the virus from spreading to others. Despite these advances,
there are still obstacles. Millions of individuals throughout the world
continue to lack access to life-saving medication, and societal and structural
factors continue to contribute to HIV's spread. People living with HIV continue
to face stigma and prejudice, emphasizing the importance of ongoing campaigning
and education. HIV research and therapy continue to advance, with potential
areas of study leading to a functional cure or total eradication of the virus.
The HIV epidemic has also emphasized the need
of global health research and innovation, spurring comparable efforts to create
novel therapies and preventative techniques for other diseases. Ending the HIV
pandemic requires multi-sectoral collaboration, community participation, and a
human rights-based strategy. The Ending the HIV Epidemic in the United States
program, for example, aims to end the HIV epidemic in the United States by
2030. To summarize, while we have made considerable progress in understanding
and controlling HIV, there is still more work to be done. We can only expect to
stop the HIV pandemic by ongoing research, activism, education, and
collaboration.
FAQ’s
HIV (Human Immunodeficiency Virus) is a virus
that attacks the body's immune system, which is crucial to fighting off
infections and diseases
AIDS (Acquired Immune Deficiency Syndrome) is a
late stage of HIV disease. A person living with HIV has AIDS when they have a
very weakened defense system or develop a serious illness that we know can be
caused by HIV
HIV is transmitted through penetrative (anal or
vaginal) sex, blood transfusion, the sharing of contaminated needles in
health-care settings and drug injection, and between mother and infant during
pregnancy, childbirth, and breastfeeding
4) Can HIV be transmitted through kissing or deep kissing?
The risk of transmitting HIV through kissing or
deep kissing is very low unless there are open sores in the mouth or blood is
present
5) Can HIV be transmitted through casual contact?
HIV is not transmitted by day-to-day contact in
social settings, schools, or the workplace. You cannot be infected by shaking
someone’s hand, by hugging someone, by using the same toilet, or drinking from
the same glass as someone living with HIV, or by being exposed to coughing or
sneezing by an infected person
6) Does HIV only affect homosexuals and drug users?
HIV can affect anyone, regardless of their
sexual orientation or whether they use drugs. It's what you do, not who you
are, that increases your chances of contracting HIV
7) What are the symptoms of HIV?
The symptoms of HIV vary, depending on the
individual and what stage of HIV they are in. In its beginning stage, HIV does
not have unique symptoms and can be indistinguishable from the flu
8) How can I avoid getting HIV?
You can avoid getting HIV by using condoms
during sex, not sharing needles, getting tested regularly, and considering
preventive measures like Pre-exposure prophylaxis (PrEP) if you are at high
risk
9) How can I get tested for HIV?
There are several ways to test for HIV, from
oral swabs to home testing kits. There are also thousands of locations across
the country where you can get an HIV test at little or no cost
10) How often should I get tested for HIV?
The Centers for Disease Control and Prevention
(CDC) recommends everyone between the ages of 13 and 64 get tested for HIV at
least once as part of their routine health care. Some people, including gay and
bisexual men and transgender women, should consider getting tested more often
11) What do I do if I have HIV?
If you have HIV, it's important to seek early
treatment and counseling to help improve and prolong the quality of life.
Currently, there is a wide range of treatments available
12) Can I get HIV from someone sneezing on me or from touching someone's
used tissue?
No, HIV is not passed on in sweat, saliva, or
tears. You can't catch it from casual contact like you can a cold or the flu
13) Can latex condoms prevent HIV?
When used consistently and correctly, latex
condoms are very good at stopping the spread of HIV during sex
14) Why should all pregnant women get tested for HIV?
HIV-positive mothers who get treatment during
pregnancy have a much lower chance of passing HIV to their baby before, during,
or after birth
15) How long does it take for HIV to cause AIDS?
Before HIV medicines became available,
Scientists used to think that about half the people with HIV developed AIDS
within 10 years after they were infected. However, current drug therapies have
dramatically changed the outlook for people living with HIV
16) What happens if I
get AIDS?
When you get infected with HIV, your body's
immune system gets weaker. The immune system is what makes your body able to
fight off infection and disease. When a person has AIDS, the immune system is
so weak it can't fight off viruses or bacteria, and it can't prevent certain
kinds of cancer the way a healthy immune system can
17) Can I transmit HIV/AIDS to my baby during pregnancy or
breastfeeding?
Yes, HIV can be passed to unborn children from
an infected mother during pregnancy or childbirth. An infected mother may also
infect her infant through breast milk
18) Is there a cure or vaccine for HIV?
As of now, there is no cure or vaccine for HIV.
However, treatments are available that can help people with HIV live healthy
lives
19) How does HIV impact the LGBT community?
While HIV is more common in some communities
than in others, anyone can acquire HIV through behaviors that are likely to
transmit the virus. It’s what you do, not who you are, that increases your
chances of contracting HIV
20) What are some recommendations for reducing the spread of HIV?
Using latex condoms consistently and correctly,
limiting or avoiding the use of drugs and alcohol, not sharing needles, and
getting tested regularly are some of the recommendations for reducing the
spread of HIV
Comments
Post a Comment